Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in PGEN — Precigen, Inc.

CIK 80255 BALTIMORE, MD
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$904,099
+$365,488 QoQ
Shares Held
158,614
+14.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. PGEN ranks #180 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $904,099 158,614
2026-03-31 $538,611 139,176
2025-12-31 $409,380 97,938
2025-09-30 $261,739 79,556
2025-06-30 $97,789 68,866
2025-03-31 $89,796 60,266
2024-12-31 $145,897 130,266
2024-09-30 $161,025 169,501
2024-06-30 $267,811 169,501
2024-03-31 $239,470 165,152
2023-12-31 $214,196 159,848
2023-09-30 $226,984 159,848
2023-06-30 $195,908 170,355
2023-03-31 $201,882 190,455
2022-12-31 $271,675 178,734
2022-09-30 $378,916 178,734
2022-06-30 $148,236 110,624
2022-03-31 $156,701 74,266
2021-12-31 $240,652 64,866
2021-09-30 $103,622 20,766
2021-06-30 $135,394 20,766
2021-03-31 $119,989 17,415
2020-12-31 $284,365 27,879
2020-09-30 $182,626 52,179
2020-06-30 $260,373 52,179
2020-03-31 $200,202 58,883